Reich O, Heinisch G, Justus J
Institut für Pathologie Georg Schmorl, Klinikums Dresden-Friedrichstadt, Deutschland.
Zentralbl Pathol. 1994 Mar;140(1):49-54.
The histological grading of 29 ductal pancreatic carcinomas was compared with that of silver stained NOR-associated proteins and with p53 immunoreactivity. The AgNOR number (NZ) and AgNOR areas (NF) of 10 grade I carcinomas, 13 grade II carcinomas and 6 grade III carcinomas were investigated by image analysis. Furthermore, the protein expression of the p53 gene was examined by immunohistochemistry. A significant difference was found in both AgNOR parameters between grade I, grade II and grade III carcinomas (NZ: p < 0.01; NF: p < 0.05; grade I carcinomas: NZ 5.1/NF 8.2 microns 2; grade II carcinomas: NZ 6.0/NF 11.3 microns 2 grade III carcinomas: NZ 8.4/NF 15.2 microns 2). By contrast no relation was found between histological grading and p53 immunoreactivity. In 56% of all carcinomas positive evidence was found of the p53 gene product. (6 grade I carcinomas, 7 grade II carcinomas, 3 grade III carcinomas). 44% of the cases were p53-negative (4 grade I carcinomas, 6 grade II carcinomas, 3 grade III carcinomas). This study demonstrates that the AgNOR technique is useful in the grading of ductal pancreatic carcinomas, whereas the expression of the p53 gene product is not.
对29例导管腺癌的组织学分级与银染核仁组织区相关蛋白及p53免疫反应性进行了比较。采用图像分析技术研究了10例I级癌、13例II级癌和6例III级癌的核仁组成区嗜银蛋白数量(NZ)和核仁组成区面积(NF)。此外,通过免疫组织化学检测p53基因的蛋白表达。I级、II级和III级癌之间的两个核仁组成区参数均存在显著差异(NZ:p<0.01;NF:p<0.05;I级癌:NZ 5.1/NF 8.2平方微米;II级癌:NZ 6.0/NF 11.3平方微米;III级癌:NZ 8.4/NF 15.2平方微米)。相比之下,未发现组织学分级与p53免疫反应性之间存在关联。在所有癌中,56%的病例检测到p53基因产物阳性证据(6例I级癌、7例II级癌、3例III级癌)。44%的病例p53呈阴性(4例I级癌、6例II级癌、3例III级癌)。本研究表明,核仁组成区嗜银蛋白技术在导管腺癌分级中有用,而p53基因产物的表达则不然。